Verano Holdings (VRNO) Other Non-Current Assets (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Other Non-Current Assets of $10.0 million for Q1 2026, down 24.69% year-over-year from $13.3 million in Q1 2025, and down 5.21% quarter-over-quarter from $10.6 million in Q4 2025.
Verano Holdings (VRNO) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Other Non-Current Assets for 6 consecutive years, with $10.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 24.69% year-over-year to $10.0 million; the TTM figure through Mar 2026 stood at $10.0 million (down 24.69% YoY), while the FY2025 annual figure was $10.6 million, down 20.76% from the prior year.
- Other Non-Current Assets declined to $10.0 million in Q1 2026 per VRNO's latest filing, from $10.6 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $14.0 million in Q2 2025 and bottomed at $2.6 million in Q2 2022.
- Historically, Other Non-Current Assets has averaged $11.2 million across 5 years, with a median of $12.9 million in 2022.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets surged 422.31% — and 2026, when it retreated 24.69%.
- Verano Holdings' Other Non-Current Assets stood at $12.8 million in 2022, then dropped by 3.27% to $12.3 million in 2023, then grew by 7.97% to $13.3 million in 2024, then slipped by 20.76% to $10.6 million in 2025, then decreased by 5.21% to $10.0 million in 2026.
- Business Quant data shows VRNO's Other Non-Current Assets at $10.0 million in Q1 2026, $10.6 million in Q4 2025, and $13.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Verano Holdings | 440.28 Mn | 355.08 Mn | 99.70 Mn | 9.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.33 Mn |
| Mar 31, 2026 | 10.02 Mn |
| Dec 31, 2025 | 10.57 Mn |
| Sep 30, 2025 | 13.14 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 13.30 Mn |
| Dec 31, 2024 | 13.33 Mn |
| Sep 30, 2024 | 13.07 Mn |
| Jun 30, 2024 | 11.28 Mn |
| Mar 31, 2024 | 10.50 Mn |
| Dec 31, 2023 | 12.35 Mn |
| Sep 30, 2023 | 13.82 Mn |
| Jun 30, 2023 | 13.31 Mn |
| Mar 31, 2023 | 13.33 Mn |
| Dec 31, 2022 | 12.77 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 2.58 Mn |
| Dec 31, 2021 | 2.50 Mn |